まとめ
ティモロールとプロプロノロールは,高血圧の男性において,血圧と心拍数を同等に低下させる. 低血圧効果は類似しており,血動力学とプラズマレニン活性に直接的な相関関係なく影響します.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
背景:
- 高血圧は,効果的な薬理学的介入を必要とする世界的な健康問題です.
- ベータブロッカーは高血圧管理に広く使用されており,ティモロールとプロプロノロールは一般的な例です.
研究 の 目的:
- 血圧,血動力学,および高血圧の男性におけるプラズマレニン活性に対するティモロールとプロプラノロールの均等な用量の効果を比較する.
主な方法:
- 高血圧の男性20人を対象としたダブルブラインド,ランダム化研究です.
- 参加者はプラセボを投与し,その後5週間にわたってティモロールまたはプロプラノロールを投与しました.
- 右心臓のキャセテリゼーションと室外出院の血圧/心拍数測定が行われました.
主要な成果:
- ティモロールとプロプラノロールの両方,シストリックとダイアストリックの血圧と心拍数を著しく低下させた.
- エキピオテント投与は,心臓指数低下を含む同様の血液動力学的効果をもたらした.
- プラズマレニン活性の大幅な低下は,両方の薬剤で観察されました.
結論:
- ティモロールとプロプラノロールは,血圧と心拍数を低下させるのに類似した有効性を示しています.
- これらのベータブロッカーの低血圧作用は,プラズマレニン活性に対する影響とは独立しています.
関連する概念動画
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...